#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12120	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2027	588.7	0	.	n	.	0	C451T	SNP	451	451	C	677	677	T	654	T,C	477,165	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12120	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2027	588.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	696	C,G	674,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22574	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3635	616.0	0	.	n	.	0	T695C	SNP	695	695	T	1057	1057	C	660	C,T	640,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22574	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3635	616.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2000	2000	G	701	G,A	498,184	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22574	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3635	616.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2333	2333	C	718	C	694	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22574	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3635	616.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2407	2407	A	746	A	728	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22574	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3635	616.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2959	2959	C	681	C	669	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	124	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1284	9.5	0	.	p	.	0	M180T	NONSYN	538	540	ATG	752	754	ACG	11;11;11	A;C;G	10;11;10	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1528	folP	855	855	100.0	folP.l15.c4.ctg.1	1660	91.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1062	1064	AGC	152;152;150	A,T;G;C	148,1;149;147	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4276	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3398	124.6	1	SNP	p	S91F	1	.	.	271	273	TTC	560	562	TTC	145;145;146	T;T;C	144;144;144	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4276	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3398	124.6	1	SNP	p	D95G	1	.	.	283	285	GGC	572	574	GGC	149;152;149	G;G;C	143;146;145	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4276	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3398	124.6	1	SNP	p	G95N	0	.	.	283	285	GGC	572	574	GGC	149;152;149	G;G;C	143;146;145	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1188	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1369	85.8	1	SNP	p	G45D	0	.	.	133	135	GGC	457	459	GGC	134;133;135	G;G,T;C	129;128,1;131	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	620	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1032	59.7	0	.	n	.	0	A197.	DEL	197	197	A	623	623	A	140	A	135	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4212	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2894	144.1	1	SNP	p	D86N	0	.	.	256	258	GAC	551	553	GAC	175;174;177	G,T;A;C	170,1;166;171	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4212	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2894	144.1	1	SNP	p	R87I	0	.	.	259	261	CGT	554	556	CGT	177;173;172	C,A;G,C;T	170,1;169,1;166	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4212	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2894	144.1	1	SNP	p	R87W	0	.	.	259	261	CGT	554	556	CGT	177;173;172	C,A;G,C;T	170,1;169,1;166	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4212	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2894	144.1	1	SNP	p	S87R	1	.	.	259	261	CGT	554	556	CGT	177;173;172	C,A;G,C;T	170,1;169,1;166	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4212	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2894	144.1	1	SNP	p	S88P	0	.	.	262	264	TCC	557	559	TCC	170;171;173	T;C;C	163;166;166	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3342	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2680	122.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1634	1636	GGC	162;159;158	G;G;C,A	158;153;151,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	27	3142	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2349	132.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1256	1258	GCC	174;174;178	G;C;C	170;167;173	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3142	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2349	132.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1259	1261	ATG	177;178;177	A;T;G,C	173;174;169,1	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3142	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2349	132.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1271	1273	ACC	171;172;172	A;C;C	161;168;168	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3142	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2349	132.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1271	1273	ACC	171;172;172	A;C;C	161;168;168	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3142	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2349	132.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1772	1774	ACC	161;160;161	A;C;C	157;159;159	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3142	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2349	132.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1826	1828	GCG	149;151;154	G;C,G;G	139;125,1;141	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3142	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2349	132.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1826	1828	GCG	149;151;154	G;C,G;G	139;125,1;141	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3142	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2349	132.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1949	1951	GGT	131;131;128	G;G,T;T,C	123;122,2;116,1	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3142	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2349	132.0	1	SNP	p	G545S	0	.	.	1633	1635	GGC	1958	1960	GGC	114;109;107	G,A;G,A;C,G	108,1;104,1;104,1	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3142	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2349	132.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1976	1978	CCG	84;84;85	C;C;G	78;77;67	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4838	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3218	148.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1700	1702	CCG	163;164;165	C;C;G	151;161;157	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1998	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1833	107.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	538	538	C	136	C	129	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2290	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1636	138.4	0	.	p	.	0	I45V	NONSYN	133	135	ATT	486	488	GTT	196;196;191	G,A;T,G;T	188,3;182,1;187	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2290	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1636	138.4	0	.	p	.	0	G48E	NONSYN	142	144	GGA	495	497	GAA	188;188;193	G;A,G;A	186;181,3;190	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2290	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1636	138.4	1	SNP	p	G120K	1	.	.	358	360	AAG	711	713	AAG	177;178;176	A,G;A,G;G,T,A	167,1;168,1;162,1,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2290	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1636	138.4	1	SNP	p	N121D	0	.	.	361	363	AAC	714	716	AAC	176;177;179	A,G;A,C;C	170,1;170,1;168	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2290	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1636	138.4	1	SNP	p	A121N	1	.	.	361	363	AAC	714	716	AAC	176;177;179	A,G;A,C;C	170,1;170,1;168	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8368	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4720	175.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	926	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1069	85.9	1	SNP	p	V57M	1	.	.	169	171	ATG	566	568	ATG	179;178;179	A;T;G	173;172;173	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
